The global blood transfusion diagnostics market is booming, projected to reach $4600 million by 2033, driven by rising blood-borne disease prevalence and advancements in rapid testing. Learn about market trends, key players (Grifols, Roche, Abbott), and future growth opportunities in this comprehensive analysis.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.
